0001237899-15-000025.txt : 20150318 0001237899-15-000025.hdr.sgml : 20150318 20150318180339 ACCESSION NUMBER: 0001237899-15-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150316 FILED AS OF DATE: 20150318 DATE AS OF CHANGE: 20150318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Terifay Robert J CENTRAL INDEX KEY: 0001391382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 15711165 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-03-16 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001391382 Terifay Robert J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Commercial Common Stock 2015-03-16 4 M 0 24375.0 30.63 A 44404 D Common Stock 2015-03-16 4 F 0 1679.0 444.46 D 42725 D Common Stock 2015-03-16 4 F 0 11703.0 444.46 D 31022 D Common Stock 2015-03-17 4 S 0 2600.0 448.01 D 28422 D Common Stock 2015-03-17 4 S 0 300.0 448.87 D 28122 D Common Stock 2015-03-17 4 S 0 2093.0 450.18 D 26029 D Common Stock 2015-03-17 4 S 0 700.0 450.95 D 25329 D Common Stock 2015-03-17 4 S 0 3200.0 452.61 D 22129 D Common Stock 2015-03-17 4 S 0 1700.0 453.28 D 20429 D Common Stock 2015-03-17 4 S 0 400.0 454.0 D 20029 D Common Stock 1651 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2015-03-16 4 M 0 24375.0 0.0 D 2020-12-14 Common Stock 24375 29236 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 2,600 shares of Company stock on March 17, 2015 at prices ranging from $447.56 to $448.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on March 17, 2015 at prices ranging from $448.60 to $449.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. Represents volume-weighted average price of sales of 2,093 shares of Company stock on March 17, 2015 at prices ranging from $449.60 to $450.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. Represents volume-weighted average price of sales of 700 shares of Company stock on March 17, 2015 at prices ranging from $450.75 to $451.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. Represents volume-weighted average price of sales of 3,200 shares of Company stock on March 17, 2015 at prices ranging from $451.99 to $452.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. Represents volume-weighted average price of sales of 1,700 shares of Company stock on March 17, 2015 at prices ranging from $452.99 to $453.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2015 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013. /s/**Robert J. Terifay 2015-03-18